These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 34379753)
1. MFAP4 deletion attenuates the progression of angiotensin II-induced atrial fibrosis and atrial fibrillation. Wang H; Liu M; Wang X; Shuai W; Fu H Europace; 2022 Feb; 24(2):340-347. PubMed ID: 34379753 [TBL] [Abstract][Full Text] [Related]
2. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice. Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477 [TBL] [Abstract][Full Text] [Related]
3. Immunoproteasome Subunit β5i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice. Li J; Wang S; Zhang YL; Bai J; Lin QY; Liu RS; Yu XH; Li HH Hypertension; 2019 Jan; 73(1):92-101. PubMed ID: 30571551 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of UCHL1 by LDN-57444 attenuates Ang II-Induced atrial fibrillation in mice. Bi HL; Zhang YL; Yang J; Shu Q; Yang XL; Yan X; Chen C; Li Z; Li HH Hypertens Res; 2020 Mar; 43(3):168-177. PubMed ID: 31700166 [TBL] [Abstract][Full Text] [Related]
6. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway. Wu Y; Can J; Hao S; Qiang X; Ning Z Cerebrovasc Dis; 2022; 51(2):188-198. PubMed ID: 34515064 [TBL] [Abstract][Full Text] [Related]
7. Novel Role for the Immunoproteasome Subunit PSMB10 in Angiotensin II-Induced Atrial Fibrillation in Mice. Li J; Wang S; Bai J; Yang XL; Zhang YL; Che YL; Li HH; Yang YZ Hypertension; 2018 May; 71(5):866-876. PubMed ID: 29507100 [TBL] [Abstract][Full Text] [Related]
8. Increased plasma microfibrillar-associated protein 4 is associated with atrial fibrillation and more advanced left atrial remodelling. Zhang X; Li H; Kou W; Tang K; Zhao D; Zhang J; Zhuang J; Zhao Y; Ji S; Peng W; Xu Y Arch Med Sci; 2019 May; 15(3):632-640. PubMed ID: 31110528 [TBL] [Abstract][Full Text] [Related]
9. The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation. Wang Q; Yu Y; Zhang P; Chen Y; Li C; Chen J; Wang Y; Li Y Basic Res Cardiol; 2017 Jul; 112(4):47. PubMed ID: 28639003 [TBL] [Abstract][Full Text] [Related]
10. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway. Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465 [TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. He X; Gao X; Peng L; Wang S; Zhu Y; Ma H; Lin J; Duan DD Circ Res; 2011 Jan; 108(2):164-75. PubMed ID: 21127293 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin I Zhang Y; Yuan M; Cai W; Sun W; Shi X; Liu D; Song W; Yan Y; Chen T; Bao Q; Zhang B; Liu T; Zhu Y; Zhang X; Li G Cell Mol Life Sci; 2024 Jun; 81(1):264. PubMed ID: 38878214 [TBL] [Abstract][Full Text] [Related]
13. Cadherin-11 Deficiency Attenuates Ang-II-Induced Atrial Fibrosis and Susceptibility to Atrial Fibrillation. Cao W; Song S; Fang G; Li Y; Wang Y; Wang QS J Inflamm Res; 2021; 14():2897-2911. PubMed ID: 34239314 [TBL] [Abstract][Full Text] [Related]
14. PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation. Hu J; Zhang JJ; Li L; Wang SL; Yang HT; Fan XW; Zhang LM; Hu GL; Fu HX; Song WF; Yan LJ; Liu JJ; Wu JT; Kong B J Cell Mol Med; 2021 Jul; 25(14):6746-6759. PubMed ID: 34132026 [TBL] [Abstract][Full Text] [Related]
15. Targeting myocardial inflammation: investigating the therapeutic potential of atrial natriuretic peptide in atrial fibrosis. Zhu N; Li T; Bai Y; Sun J; Guo J; Yuan H; Shan Z Mol Biol Rep; 2024 Apr; 51(1):506. PubMed ID: 38622341 [TBL] [Abstract][Full Text] [Related]
16. Costunolide ameliorates angiotensin II-induced atrial inflammation and fibrosis by regulating mitochondrial function and oxidative stress in mice: A possible therapeutic approach for atrial fibrillation. Liu Y; Wang D; Jin Y; Sun G; Lou Q; Wang H; Li W Microvasc Res; 2024 Jan; 151():104600. PubMed ID: 37666318 [TBL] [Abstract][Full Text] [Related]
17. Induction of atrial fibrillation by neutrophils critically depends on CD11b/CD18 integrins. Friedrichs K; Adam M; Remane L; Mollenhauer M; Rudolph V; Rudolph TK; Andrié RP; Stöckigt F; Schrickel JW; Ravekes T; Deuschl F; Nickenig G; Willems S; Baldus S; Klinke A PLoS One; 2014; 9(2):e89307. PubMed ID: 24558493 [TBL] [Abstract][Full Text] [Related]
18. Xu B; Xu Y; Ren W; Meng S; Hong T; Cao Z; Xiao X; Guo X; Yu L; Zhao J; Wang H Food Funct; 2024 Sep; 15(18):9165-9175. PubMed ID: 39157962 [TBL] [Abstract][Full Text] [Related]
19. Salidroside attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II through inhibition of LOXL2-TGF-β1-Smad2/3 pathway. Hai Z; Wu Y; Ning Z Heliyon; 2023 Nov; 9(11):e21220. PubMed ID: 37920527 [TBL] [Abstract][Full Text] [Related]
20. Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts. Liu Y; Lv H; Tan R; An X; Niu XH; Liu YJ; Yang X; Yin X; Xia YL Hypertension; 2020 Dec; 76(6):1856-1867. PubMed ID: 33175633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]